News
CBLI
--
0.00%
--
Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"
, /PRNewswire/ -- , a leading biopharmaceutical company creating second generation immune therapies, announced today that the company is participating in Biotech Showcase Digital and H.C. Wainwright BioConnect.  Both events will be held virtually and are ...
PR Newswire - PRF · 12/22/2020 12:35
Cytocom to Participate in Biotech Showcase and H.C. Wainwright BioConnect 2021 During "J.P. Morgan Week 2021"
Cytocom, Inc., a leading biopharmaceutical company creating second generation immune therapies, announced today that the company is participating in Biotech Showcase Digital and H.C. Wainwright BioConnect. Both events will be held virtually and are schedul...
PR Newswire · 12/22/2020 12:35
AJRD, AJIO, NK and LAZR among premarket gainers
EyeGate Pharmaceuticals (EYEG) +87% as it acquires Panoptes Pharma.NantKwest (NK) +32% as its partner, ImmunityBio, achieves primary endpoint in bladder cancer study.RealPage (RP) +31% as Thoma Bravo has agreed to buy the company
Seekingalpha · 12/21/2020 13:26
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies ALXN, ELY, CLCT, CBLI
NEW YORK, NY / ACCESSWIRE / December 19, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:Alexion Pharmaceuticals, Inc.
ACCESSWIRE · 12/19/2020 19:15
Cleveland BioLabs Inc US Patent Number 10,857,200 Titled 'Methods and compositions for the treatment of radiation-related disorders'
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=10857200&OS=10857200&RS=10857200
Benzinga · 12/08/2020 19:28
MERGER ALERT - VABK, CBLI, and RESI: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies
NEW YORK, NY / ACCESSWIRE / October 21, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.
ACCESSWIRE · 10/21/2020 15:45
Cytocom, Inc. Issues Shareholder Letter To Stockholders Of Cytocom And BioLabs
  WINTER PARK, Fla., Oct. 21, 2020 /PRNewswire/ -- Cytocom, Inc., a leading biopharmaceutical company in the area of immune-modulation, today announced that its Chief Executive Officer, Michael K. Handley, has
Benzinga · 10/21/2020 12:32
Netflix, GSX Techedu leads premarket losers' pack
GSX Techedu (GSX) -24%.Armstrong Flooring (AFI) -22% after Q3 earnings.Iterum Therapeutics (ITRM) -18%.China Index Holdings (CIH) -15%.Code Chain New Continent (CCNC) -14%.Dragon Victory International (LYL) -12%.CRISPR Therapeutics (CRSP) -11% after announcing positive top-line
Seekingalpha · 10/21/2020 12:28
The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 20)
Benzinga · 10/21/2020 12:04
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Cleveland BioLabs, Inc. (NASDAQ:CBLI)
BALA CYNWYD, PA / ACCESSWIRE / October 20, 2020 / Law Office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cleveland BioLabs, Inc.
ACCESSWIRE · 10/20/2020 23:51
Mid-Afternoon Market Update: Dow Rises 1%; Aptinyx Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded up 1% to 28,476.42 while the NASDAQ rose 1.06% to 11,600.59. The S&P also rose, gaining 1.15% to 3,466.20.
Benzinga · 10/20/2020 18:34
NNDM, CIH, BCLI and CBLI among midday movers
Gainers: Cleveland BioLabs (CBLI) +66%.9F (JFU) +47%.Molecular Data (MKD) +35%.Natuzzi (NTZ) +30%.Aptinyx (APTX) +26%.VOXX International (VOXX) +23%.Pro-Dex (PDEX) +21%.SunLink Health Systems (SSY) +21%.China Index Holdings (CIH) +14%.Anchiano Therapeutics (ANCN) +11%.Losers: Kaixin Auto
Seekingalpha · 10/20/2020 16:38
Mid-Day Market Update: Cleveland BioLabs Jumps On Merger News; Isoray Shares Slide
Midway through trading Tuesday, the Dow traded up 0.42% to 28313.84 while the NASDAQ rose 0.26% to 11508.37. The S&P also rose, gaining 0.45% to 3442.37.
Benzinga · 10/20/2020 16:12
Why Cleveland BioLabs Stock Is Trading Higher Today
Cleveland BioLabs (NASDAQ: CBLI) shares are trading higher on Tuesday after the company, along with Cytocom, announced they have entered into a definitive merger agreement to combine their businesses in an all-stock transaction.
Benzinga · 10/20/2020 15:08
Cleveland BioLabs, Anchiano Therapeutics leads healthcare gainers, Baudax Bio, BOQI International Medical among major losers
Gainers: Cleveland BioLabs (CBLI) +96%, Anchiano Therapeutics (ANCN) +46%, Aptinyx (APTX) +45%, SOS (SOS) +21%, Liquidia Technologies (LQDA) +18%.Losers: Baudax Bio (BXRX) -37%, BOQI International Medical (BIMI) -13%, Midatech Pharma (MTP) -11%, China Jo-Jo Drugstores (CJJD) -9%, Calithera Biosciences (CALA) -9%.
Seekingalpha · 10/20/2020 14:53
Mid-Morning Market Update: Markets Open Higher; Procter & Gamble Beats Q1 Views
Following the market opening Tuesday, the Dow traded up 0.82% to 28425.94 while the NASDAQ rose 0.84% to 11575.60. The S&P also rose, gaining 0.90% to 3,457.87.
Benzinga · 10/20/2020 14:16
LOGI, PE among premarket gainers
Aptinyx (APTX) +98% on reporting positive top-line data from Phase 2 study of NYX-783.Cleveland BioLabs (CBLI) +46% in reaction to its planned merger with biopharmaceutical outfit Cytocom.Recon Technology (RCON) +42%.ATIF Holdings (ATIF) +26% after entering into
Seekingalpha · 10/20/2020 12:24
The Daily Biotech Pulse: Aptinyx Jumps On Positive Readout, Cara Executes Korsuva Licensing Deal, Cleveland BioLabs Rallies On Reverse Merger
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 19)
Benzinga · 10/20/2020 12:17
Cleveland BioLabs up 66% on planned merger with Cytocom
Thinly traded nano cap Cleveland BioLabs (CBLI) jumps 66% premarket on robust volume in reaction to its planned merger with biopharmaceutical outfit Cytocom in an all-stock transaction. The latter will be majority
Seekingalpha · 10/20/2020 12:02
Cytocom And Cleveland BioLabs Announce Definitive Merger Agreement To Combine Businesses In All-Stock Transaction; Cytocom Shareholders Will Have A Majority Position In The Newly Combined Entity
Merger to create a single public company focused on the development and commercialization of immunotherapies for oncology, infectious disease, inflammation and auto-immune mediated conditions WINTER PARK, FL and
Benzinga · 10/19/2020 20:12
Webull provides a variety of real-time CBLI stock news. You can receive the latest news about Cleveland Biolbs through multiple platforms. This information may help you make smarter investment decisions.
About CBLI
Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product candidate is Entolimod, an immuno-stimulatory agent, which it is developing as a radiation countermeasure and an immunotherapy for oncology and other indications. Its other products include CBLB612, Mobilan and CBL0137. CBLB612 is a compound based upon a natural activator of another tissue-specific component of the innate immune system, the toll-like receptor 2 (TLR2)/ toll-like receptor 6 (TLR6) heterodimeric receptor. Mobilan is a recombinant non-replicating adenovirus that directs expression of TLR5 and its agonistic ligand. CBL0137 is a small molecule with a multi-targeted mechanism of action that may be useful for the treatment of various types of cancer.
More